AU1157292A - Bridged cyclic ketal derivatives - Google Patents

Bridged cyclic ketal derivatives

Info

Publication number
AU1157292A
AU1157292A AU11572/92A AU1157292A AU1157292A AU 1157292 A AU1157292 A AU 1157292A AU 11572/92 A AU11572/92 A AU 11572/92A AU 1157292 A AU1157292 A AU 1157292A AU 1157292 A AU1157292 A AU 1157292A
Authority
AU
Australia
Prior art keywords
bridged cyclic
cyclic ketal
ketal derivatives
derivatives
bridged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11572/92A
Inventor
Barrie Edward Kirk
Michael George Lester
Panayiotis Alexandrou Procopiou
Barry Clive Ross
Philip James Sidebottom
Nigel Stephen Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1157292A publication Critical patent/AU1157292A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
AU11572/92A 1991-01-09 1992-01-05 Bridged cyclic ketal derivatives Abandoned AU1157292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919100431A GB9100431D0 (en) 1991-01-09 1991-01-09 Chemical compounds
GB9100431 1991-01-09

Publications (1)

Publication Number Publication Date
AU1157292A true AU1157292A (en) 1992-08-17

Family

ID=10688179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11572/92A Abandoned AU1157292A (en) 1991-01-09 1992-01-05 Bridged cyclic ketal derivatives

Country Status (3)

Country Link
AU (1) AU1157292A (en)
GB (1) GB9100431D0 (en)
WO (1) WO1992012157A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU640520B2 (en) * 1990-09-13 1993-08-26 Merck & Co., Inc. Novel squalene synthetase inhibitors

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506262A (en) * 1991-05-10 1996-04-09 Merck & Co., Inc. Cholesterol lowering compounds
US5256689A (en) * 1991-05-10 1993-10-26 Merck & Co., Inc. Cholesterol lowering compounds
US5294627A (en) * 1992-08-27 1994-03-15 Merck & Co., Inc. Directed biosynthesis of biologically active compounds
US5302604A (en) * 1992-03-09 1994-04-12 Merck & Co., Inc. Cholesterol lowering compounds produced by directed biosynthesis
US5369125A (en) * 1992-07-17 1994-11-29 Merck & Co., Inc. Cholesterol-lowering agents
US5283256A (en) * 1992-07-22 1994-02-01 Merck & Co., Inc. Cholesterol-lowering agents
US5326783A (en) * 1992-08-25 1994-07-05 Merck & Co., Inc. Cholesterol lowering compounds
US5278320A (en) * 1992-09-11 1994-01-11 Merck & Co., Inc. Cholesterol lowering compounds produced by directed biosynthesis
US5332728A (en) * 1992-11-23 1994-07-26 Bristol-Myers Squibb Company Method for treating a fungal infection
US5447717A (en) * 1993-02-25 1995-09-05 Merck & Co., Inc. Cholesterol-lowering agents
US5712261A (en) * 1993-10-04 1998-01-27 Magnin; David R. Method for preventing or treating hypertriglyceridemia
US5430055A (en) * 1994-04-08 1995-07-04 Pfizer Inc. Inhibitor of squalene synthase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606071A5 (en) * 1972-05-30 1978-10-13 Ciba Geigy Ag Fibrinolytic anhydro-furanose ether derivs.
US4837205A (en) * 1986-09-02 1989-06-06 Merck & Co., Inc. Prodrugs of antihypercholesterolemic compounds
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU640520B2 (en) * 1990-09-13 1993-08-26 Merck & Co., Inc. Novel squalene synthetase inhibitors

Also Published As

Publication number Publication date
GB9100431D0 (en) 1991-02-20
WO1992012157A1 (en) 1992-07-23

Similar Documents

Publication Publication Date Title
AU1154692A (en) Bridged cyclic ketal derivatives
AU653734B2 (en) Substituted 4-biphenylmethoxypyridine derivatives
AU644249B2 (en) Alpha-oxoacetamide derivatives
AU1655192A (en) Antivizal dibenzothiazepinone derivatives
AU2452992A (en) Benzanilide derivatives
AU2452892A (en) Benzanilide derivatives
AU4624993A (en) Cyclic urea derivatives
AU4714789A (en) Cyclic ether derivatives
AU7707591A (en) Hydroquinazoline derivatives
AU7500891A (en) Benzimidazolinone derivatives
AU1632192A (en) Benzofuran derivatives
AU6860691A (en) Azaoxindole derivatives
AU1352792A (en) Cyclic ketal derivatives
AU7203891A (en) Novel tetrahydropyridine derivatives
AU1864092A (en) Cyclic imide derivatives
AU1158292A (en) Cyclic ketal derivatives
AU2817092A (en) Oxime derivatives
AU1157292A (en) Bridged cyclic ketal derivatives
AU1751192A (en) Benzofuran derivatives
AU7825291A (en) Pyridinypiperazine derivatives
AU3822393A (en) Cyclic imino derivatives
AU4456293A (en) 1, 4-Benzodioxane derivatives
AU1033992A (en) 3-quinuclidine derivatives
AU7390791A (en) Furopyrimidine derivatives
AU2686592A (en) Tetraphenylporphyn derivatives